High incidence of idiopathic nephrotic syndrome in East Asian children: a nationwide survey in Japan (JP-SHINE study)

Clinical and Experimental Nephrology

Volumn 21, Issue 4, 2017, Pages 651-657

  Kikunaga, Kaori ^a   Ishikura, Kenji ^a,b   Terano, Chikako ^a   Sato, Mai ^b   Komaki, Fumiyo ^c   Hamasaki, Yuko ^d   Sasaki, Satoshi ^e   Iijima, Kazumoto ^f   Yoshikawa, Norishige ^g   Nakanishi, Koichi ^g   Nakazato, Hitoshi ^h   Matsuyama, Takeshi ⁱ   Ando, Takashi ^j   Ito, Shuichi ^b,k   Honda, Masataka ^a  

^a TOKYO METROPOLITAN CHILDREN'S MEDICAL CENTER   (Japan)

^b NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^c Kawasaki City Children and Family Welfare Center   (Japan)

^d TOHO UNIVERSITY   (Japan)

^e HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^h KUMAMOTO UNIVERSITY   (Japan)

ⁱ Fussa Hospital   (Japan)

^j Japan Clinical Research Support Unit   (Japan)

^k YOKOHAMA CITY UNIVERSITY   (Japan)

more..

Author keywords

Asia; Children; Epidemiological study; Idiopathic nephrotic syndrome; Incidence; Nationwide survey

Indexed keywords

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; CHILD; CHILD UROLOGY; CHILDHOOD MORTALITY; CLINICAL OUTCOME; CROSS-SECTIONAL STUDY; FEMALE; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HEALTH SURVEY; HUMAN; INCIDENCE; INFANT; JAPAN; MAJOR CLINICAL STUDY; MALE; NEPHROTIC SYNDROME; PRESCHOOL CHILD; SCHOOL CHILD; SEX RATIO; CLINICAL TRIAL; MULTICENTER STUDY; RECURRENT DISEASE; TIME FACTOR;

ADOLESCENT; AGE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; INCIDENCE; INFANT; JAPAN; MALE; NEPHROTIC SYNDROME; RECURRENCE; SEX DISTRIBUTION; TIME FACTORS;

EID: 84984910907     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-016-1319-z     Document Type: Article

References (28)

1. Eddy AA, Symons JM. Nephrotic syndrome in childhood. Lancet. 2003;362:629–39.
2. van Husen M, Kemper MJ. New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome. Pediatr Nephrol. 2011;26:881–92.
3. Kengne-Wafo S, Massella L, Diomedi-Camassei F, Gianviti A, Vivarelli M, Greco M, Stringini GR, Emma F. Risk factors for cyclosporin A nephrotoxicity in children with steroid-dependant nephrotic syndrome. Clin J Am Soc Nephrol. 2009;4:1409–16.
4. Pravitsitthikul N, Willis NS, Hodson EM, Craig JC. Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children. Cochrane Database Syst Rev. 2013;10:CD002290.
5. Warady BA, Chadha V. Chronic kidney disease in children: the global perspective. Pediatr Nephrol. 2007;22:1999–2009.
6. Harambat J, van Stralen KJ, Kim JJ, Tizard EJ. Epidemiology of chronic kidney disease in children. Pediatr Nephrol. 2012;27:363–73.
7. Wong W. Idiopathic nephrotic syndrome in New Zealand children, demographic, clinical features, initial management and outcome after twelve-month follow-up: results of a three-year national surveillance study. J Paediatr Child Health. 2007;43:337–41.
8. El Bakkali L, Rodrigues Pereira R, Kuik DJ, Ket JC, van Wijk JA. Nephrotic syndrome in The Netherlands: a population-based cohort study and a review of the literature. Pediatr Nephrol. 2011;26:1241–6.
9. Chang JW, Tsai HL, Yang LY, Chen TJ. Epidemiology and predictors of end-stage renal disease in Taiwanese children with idiopathic nephrotic syndrome. J Epidemiol. 2012;22:517–22.
10. Ernould S, Godron A, Nelson JR, Rigothier C, Llanas B, Harambat J. Idiopathic nephrotic syndrome in children: incidence, clinical presentation, and outcome in the county of Gironde, France. Arch Pediatr. 2011;18:522–8 (in French).
11. Feehally J, Kendell NP, Swift PG, Walls J. High incidence of minimal change nephrotic syndrome in Asians. Arch Dis Child. 1985;60:1018–20.
12. McKinney PA, Feltbower RG, Brocklebank JT, Fitzpatrick MM. Time trends and ethnic patterns of childhood nephrotic syndrome in Yorkshire, UK. Pediatr Nephrol. 2001;16:1040–4.
13. Sharples PM, Poulton J, White RH. Steroid responsive nephrotic syndrome is more common in Asians. Arch Dis Child. 1985;60:1014–7.
14. Ishikura K, Matsumoto S, Sako M, Tsuruga K, Nakanishi K, Kamei K, Saito H, Fujinaga S, Hamasaki Y, Chikamoto H, Ohtsuka Y, Komatsu Y, Ohta T, Nagai T, Kaito H, Kondo S, Ikezumi Y, Tanaka S, Kaku Y, Iijima K. Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: medical therapy. Clin Exp Nephrol. 2015;19:6–33.
15. Kaku Y, Ohtsuka Y, Komatsu Y, Ohta T, Nagai T, Kaito H, Kondo S, Ikezumi Y, Tanaka S, Matsumoto S, Sako M, Tsuruga K, Nakanishi K, Kamei K, Saito H, Fujinaga S, Hamasaki Y, Chikamoto H, Ishikura K, Iijima K. Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: general therapy. Clin Exp Nephrol. 2015;19:34–53.
16. Hashimoto S, Fukutomi K, Nagai M, Nakamura Y, Yanagawa H, Sasaki R, Ohno Y. A note on methods for estimating the number of patients in the nationwide epidemiological survey on intractable diseases. Nihon Koshu Eisei Zasshi. 1990;37:768–74 (in Japanese).
17. Srivastava T, Simon SD, Alon US. High incidence of focal segmental glomerulosclerosis in nephrotic syndrome of childhood. Pediatr Nephrol. 1999;13:13–8.
18. Zaki M, Helin I, Manandhar DS, Hunt MC, Khalil AF. Primary nephrotic syndrome in Arab children in Kuwait. Pediatr Nephrol. 1989;3:218–20 (discussion 221).
19. Jin DK, Kohsaka T, Tanaka M, Abe J, Kobayashi N. Human leukocyte antigens in childhood idiopathic nephrotic syndrome. Acta Paediatr Jpn. 1991;33:709–13.
20. Yoshikawa N, Nakanishi K, Sako M, Oba MS, Mori R, Ota E, Ishikura K, Hataya H, Honda M, Ito S, Shima Y, Kaito H, Nozu K, Nakamura H, Igarashi T, Ohashi Y, Iijima K. A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for 2 months is not inferior to six-month treatment. Kidney Int. 2015;87:225–32.
21. Nakanishi K, Iijima K, Ishikura K, Hataya H, Nakazato H, Sasaki S, Honda M, Yoshikawa N. Two-year outcome of the ISKDC regimen and frequent-relapsing risk in children with idiopathic nephrotic syndrome. Clin J Am Soc Nephrol. 2013;8:756–62.
22. Sinha A, Saha A, Kumar M, Sharma S, Afzal K, Mehta A, Kalaivani M, Hari P, Bagga A. Extending initial prednisolone treatment in a randomized control trial from 3 to 6 months did not significantly influence the course of illness in children with steroid-sensitive nephrotic syndrome. Kidney Int. 2015;87:217–24.
23. Tarshish P, Tobin JN, Bernstein J, Edelmann CM Jr. Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children. J Am Soc Nephrol. 1997;8:769–76.
24. Fakhouri F, Bocquet N, Taupin P, Presne C, Gagnadoux MF, Landais P, Lesavre P, Chauveau D, Knebelmann B, Broyer M, Grunfeld JP, Niaudet P. Steroid-sensitive nephrotic syndrome: from childhood to adulthood. Am J Kidney Dis. 2003;41:550–7.
25. Ruth EM, Kemper MJ, Leumann EP, Laube GF, Neuhaus TJ. Children with steroid-sensitive nephrotic syndrome come of age: long-term outcome. J Pediatr. 2005;147:202–7.
26. Ishikura K, Yoshikawa N, Nakazato H, Sasaki S, Nakanishi K, Matsuyama T, Ito S, Hamasaki Y, Yata N, Ando T, Iijima K, Honda M. Morbidity in children with frequently relapsing nephrosis: 10-year follow-up of a randomized controlled trial. Pediatr Nephrol. 2015;30:459–68.
27. Hamasaki Y, Yoshikawa N, Nakazato H, Sasaki S, Iijima K, Nakanishi K, Matsuyama T, Ishikura K, Ito S, Kaneko T, Honda M. Prospective 5-year follow-up of cyclosporine treatment in children with steroid-resistant nephrosis. Pediatr Nephrol. 2013;28:765–71.
28. Dossier C, Sellier-Leclerc AL, Rousseau A, Michel Y, Gautheret-Dejean A, Englender M, Madhi F, Charbit M, Ulinski T, Simon T, Jacqz-Aigrain E, Deschenes G. Prevalence of herpesviruses at onset of idiopathic nephrotic syndrome. Pediatr Nephrol. 2014;29:2325–31.